Abstract:The genomic response to BMP was investigated by ectopic expression of activated BMP type I receptors in C2C12 myoblast using cDNA microarrays. Novel BMP receptor target genes with possible roles in inhibition of myoblast differentiation and stimulation of osteoblast differentiation were identified. Introduction: Bone morphogenetic proteins (BMPs) have an important role in controlling mesenchymal cell fate and mediate these effects by regulating gene expression. BMPs signal through three distinct specific BMP type I receptors (also termed activin receptor-like kinases) and their downstream nuclear effectors, termed Smads. The critical target genes by which activated BMP receptors mediate change cell fate are poorly characterized. Materials and Methods: We performed transcriptional profiling of C2C12 myoblasts differentiation into osteoblast-like cells by ectopic expression of three distinct constitutively active (ca)BMP type I receptors using adenoviral gene transfer. Cells were harvested 48 h after infection, which allowed detection of both early and late response genes. Expression analysis was performed using the mouse GEM1 microarray, which is comprised of approximately 8700 unique sequences. Hybridizations were performed in duplicate with a reverse fluor labeling. Genes were considered to be significantly regulated if the p value for differential expression was less than 0.01 and inverted expression ratios per duplicate successful reciprocal hybridizations differed by less than 25%. Results and Conclusions: Each of the three caBMP type I receptors stimulated equal levels of R-Smad phosphorylation and alkaline phosphatase activity, an early marker for osteoblast differentiation. Interestingly, all three type I receptors induced identical transcriptional profiles; 97 genes were significantly upregulated and 103 genes were downregulated. Many extracellular matrix genes were upregulated, muscle-related genes downregulated, and transcription factors/signaling components modulated. In addition to 41 expressed sequence tags without known function and a number of known BMP target genes, including PPAR-gamma and fibromodulin, a large number of novel BMP target genes with an annotated function were identified, including transcription factors HesR1, ITF-2, and ICSBP, apoptosis mediators DRP-1 death kinase and ZIP kinase, IkappaBalpha, Edg-2, ZO-1, and E3 ligase Dactylin. These target genes, some of them unexpected, offer new insights into how BMPs elicit biological effects, in particular into the mechanism of inhibition of myoblast differentiation and stimulation of osteoblast differentiation.

Measurement of Constitutive Activity of BMP Type I Receptors

Bone Morphogenetic Protein Receptors: Structure, Function and Targeting by Selective Small Molecule Kinase Inhibitors

Insight into Molecular Mechanism for Activin A-Induced Bone Morphogenetic Protein Signaling

The Biological Function of Type I Receptors of Bone Morphogenetic Protein in Bone

Alk2 R206h Mutation Linked to Fibrodysplasia Ossificans Progressiva Confers Constitutive Activity to the Bmp Type I Receptor and Sensitizes Mesenchymal Cells to Bmp-Induced Osteoblast Differentiation and Bone Formation

Biphasic effects of transforming growth factor β on bone morphogenetic protein-induced osteoblast differentiation

Subtle differences in the mitogenic effects of recombinant human bone morphogenetic proteins −2 to −7 on DNA synthesis on primary bone-forming cells and identification of BMP-2/4 receptor

Divergent activities of osteogenic BMP2, and tenogenic BMP12 and BMP13 independent of receptor binding affinities

An assay for the determination of biologically active bone morphogenetic proteins using cells transfected with an inhibitor of differentiation promoter-luciferase construct.

Gene array analysis of bone morphogenetic protein type I receptor-induced osteoblast differentiation.

Functional characterization of bone morphogenetic protein binding sites and Smad1/5 activation in human vascular cells.

Identification of Type I Receptors for Osteogenic Protein-1 and Bone Morphogenetic Protein-4.

A Rapid and Sensitive Bioassay to Measure Bone Morphogenetic Protein Activity

Molecular Recognition in Bone Morphogenetic Protein (bmp)/receptor Interaction

Signal Transduction of Bone Morphogenetic Proteins in Osteoblast Differentiation.

Distinct Spatial and Temporal Expression Patterns of Two Type I Receptors for Bone Morphogenetic Proteins During Mouse Embryogenesis.

Bone Morphogenetic Protein Receptor Signal Transduction in Human Disease

Promiscuous signaling of ligands via mutant ALK2 in fibrodysplasia ossificans progressiva

Molecular basis of ALK1-mediated signalling by BMP9/BMP10 and their prodomain-bound forms

Controlling Cell Fate By Bone Morphogenetic Protein Receptors

Constitutive Activation of Activin Receptor-like Kinase 2 in Human Breast Cancer Cells inhibits Metastatic Progression and Osteolytic Bone Lesions